Pulished Date August, 2019
ID: 121
Share on
Share on

Global In-Vitro Diagnostics (IVD) Market Analysis - By Product (instruments, Reagents And Kits, Data Management System/software And Services), By Technology (Clinical Chemistry, Hematology, Immunoassays, Coagulation & Hemostasis, Molecular Diagnostics, Microbiology, Other IVD Technologies), By Application (Diabetes, Infectious Diseases, Oncology/Cancer, Cardiology, Nephrology, Autoimmune Diseases, Drug Testing, HIV), By Region - Industry Analysis, Size, Share, Growth, Trends, Forecast | 2019 - 2024

Pulished: August, 2019
ID: 121
Pages: 180

Global IVD Market Size & Growth (2019 - 2024)

As per the report, the size of the Global In-Vitro diagnostics market has been estimated at USD 70.01 billion in 2019 and is expected to reach 91.93 billion by 2024 growing at a Compound Annual Growth Rate (CAGR) of 5.6%.

Key Market Growth Drivers

  • Increasing incidences of various health disorders across the world is a key driving factor for the Global In-Vitro diagnostics market to grow eventually.
  • In-vitro diagnostics procedure is highly accurate and gives fast results with high sensitivity and this attribute is making the market demand to move forward.
  • The rise in the demand to improve the quality of diagnostics and treatment procedures in healthcare centers is accelerating the growth of the global In-vitro diagnostics market.
  • Growing focus on the development of new techniques in favor of the end-users is propelling the demand of the market.
  • In addition, the prevalence of early diagnosis of the disease which will promote the wellbeing of the patient after treatment is lavishing the growth of this market. Also, growing awareness over the point of care testing devices everywhere is fuelling the demand of the market.
  • Increasing diabetic patients globally are elevating the growth rate of the market. 

Major Challenges

  • However, the dearth of skilled persons in performing these procedures effectively due to less training programs is slightly hampering the demand of the global in-vitro diagnostics market.
  • Fluctuations in the prices of final products used in the laboratories are impeding the growth rate of this market.
  • Stringent rules and regulations by the government for approving newly launched products remains as a challenging factor for the market.
  • Lack of standardization other attributes declining the growth rate of the market. 

Potential Opportunities

  • Investments on the development of innovative diagnostic procedures are merely to set up growth opportunities for the market.
  • Launch of new devices in favor of the end-users is also greatly influencing the demand of the market.
  • Growing awareness over the availability of various techniques among people is also ascribed to outshine the demand of the market to the extent.
  • Increasing the production rate of the equipment from the past decade is enhancing the growth rate of the global in-vitro diagnostics market. 

Key happenings in this market in the recent past:

REPORT COVERAGE

REPORT METRIC

DETAILS

Market Size Available

2018 – 2024

Base Year

2018

Forecast Period

2019 - 2024

Segments Covered

By Product, Technology, Application, Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, APAC, Latin America, Middle East & Africa

Market Leaders Profiled

Abbott Laboratories, Johnson and Johnson, Siemens Healthcare, Becton Dickinson, Roche Diagnostics, Beckman Coulter Inc., Biomérieux, Ortho Clinical Diagnostics, Inc., Bio-Rad Laboratories, Inc., Danaher Corporation, Sysmex Corporation and Thermo Fisher Scientific, Inc.

 

This research report on the Global In-Vitro Diagnostics market has been segmented and sub-segmented into the following categories and analyzed market size & forecast for each segment until 2024.

In-Vitro Diagnostics Market Analysis - By Product

  • Instruments
  • Reagents and Kits
  • Software

On the basis of product type, reagents and kits product type is holding the highest shares of the market. Increasing the utilization of different devices in laboratories to ensure performance levels in the biotechnology field is prompting the demand of the market. 

In-Vitro Diagnostics Market Analysis - By Technology

  • Clinical Chemistry
  • Hematology
  • Immunoassays
  • Coagulation and Hemostasis
  • Molecular Diagnostics
  • Microbiology
  • Other IVD technologies

On the basis of technology, the Clinical chemistry segment is accounted for in holding the largest shares of the market. Increasing demand to develop quality products with the help of appropriate technology is leveraging the demand of the market. 

In-Vitro Diagnostics Market Analysis - By Application

  • Diabetes
  • Infectious Diseases
  • Oncology/Cancer
  • Cardiology
  • Nephrology
  • Autoimmune Diseases
  • Drug Testing
  • HIV

On the basis of application, the Oncology/Cancer segment is having the fastest growth rate from recent years and is also to continue the same in the coming years. The growing aging population is one of the most common factors gearing up the demand of the market. 

Regional Analysis:

North America is the largest market for In-Vitro diagnostics accounting for a share of around 37% owing to the growing prevalence of chronic diseases such as cancer and respiratory diseases in the region while Asia-Pacific is estimated to be the fastest-growing segment with a CAGR of 6.4%.

Top companies in the market

Abbott Laboratories, Johnson and Johnson, Siemens Healthcare, Becton Dickinson, Roche Diagnostics, and Beckman Coulter Inc. are the major players dominating the global IVD market.

Other companies that account for a significant share in the IVD market are Biomérieux, Ortho Clinical Diagnostics, Inc., Bio-Rad Laboratories, Inc., Danaher Corporation, Sysmex Corporation and Thermo Fisher Scientific, Inc.

  1. Introduction
    1. Market Definition
    2. Study Deliverables
    3. Base Currency, Base Year and Forecast Periods
    4. General Study Assumptions
  2. Research Methodology
    1. Introduction
    2. Research Phases
      1. Secondary Research
      2. Primary Research
      3. Econometric Modelling
      4. Expert Validation
    3. Analysis Design
    4. Study Timeline
  3. Overview
    1. Executive Summary
    2. Key Inferences
    3. New Developments
  4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
    1. Market Drivers
    2. Market Restraints
    3. Key Challenges
    4. Current Opportunities in the Market
  5. Market Segmentation
    1. Product
      1. Introduction
      2. Instruments
      3. Reagents and Kits
      4. Software
    2. Technology
      1. Introduction
      2. Clinical Chemistry
      3. Haematology
      4. Immunoassays
      5. Coagulation and Hemostasis
      6. Molecular Diagnostics
      7. Microbiology
      8. Other IVD technologies
    3. Application
      1. Introduction
      2. Diabetes
      3. Infectious Diseases
      4. Oncology/Cancer
      5. Cardiology
      6. Nephrology
      7. Autoimmune Diseases
      8. Drug Testing
      9. HIV
  6. Geographical Analysis
    1. North America
      1. Introduction
      2. United States
      3. Canada
    2. Europe
      1. Introduction
      2. U K
      3. Spain
      4. Germany
      5. Italy
      6. France
    3. Asia-Pacific
      1. Introduction
      2. China
      3. India
      4. Japan
    4. Latin America
      1. Introduction
      2. Brazil
      3. Rest of Latin America
    5. Middle East & Africa
      1. Introduction
      2. Middle-East
      3. South Africa
      4. Rest of Middle East & Africa
  7. Strategic Analysis
    1. PESTLE analysis
      1. Political
      2. Economic
      3. Social
      4. Technological
      5. Legal
      6. Environmental
    2. Porter’s Five analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Consumers
      3. Threat of New Entrants
      4. Threat of Substitute Products and Services
      5. Competitive Rivalry within the Industry
  8. Market Leaders' Analysis
    1. Abbott LaboratoriesOverview
      1. Product Analysis
      2. Strategic Evaluation and Operations
      3. Financial analysis
      4. Legal issues
      5. Recent Developments
      6. SWOT analysis
      7. Analyst View
    2. Johnson and Johnson
    3. Siemens Healthcare
    4. Becton Dickinson
    5. Roche Diagnostics
    6. Beckman Coulter Inc.
    7. Biomérieux
    8. Ortho Clinical Diagnostics, Inc.
    9. Bio-Rad Laboratories, Inc.
    10. Danaher Corporation
    11. Sysmex Corporation
    12. Thermo Fisher Scientific, Inc.
  9. Competitive Landscape
    1. Market share analysis
    2. Merger and Acquisition Analysis
    3. Agreements, collaborations and Joint Ventures
    4. New Product Launches
  10. Expert Opinions
    1. Market Outlook
    2. Investment Opportunities
  11. Appendix
    1. List of Tables
    2. List of Figures
  • Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Global In-Vitro Diagnostics Market Market By Region, From 2019 - 2024 (USD Million)
  2. Global In-Vitro Diagnostics Market Market By Type, From 2019 - 2024 (USD Million)
  3. Global Instruments Market By Region, From 2019 - 2024 (USD Million) 
  4. Global Reagents and Kits Market By Region, From 2019 - 2024 (USD Million)   
  5. Global Software Market By Region, From 2019 - 2024 (USD Million)
  6. Global Clinical Chemistry Market By Region, From 2019 - 2024 (USD Million)   
  7. Global Hematology Market By Region, From 2019 - 2024 (USD Million) 
  8. Global Immunoassays Market By Region, From 2019 - 2024 (USD Million)
  9. Global Coagulation and Hemostasis Market By Region, From 2019 - 2024 (USD Million) 
  10. Global Molecular Diagnostics Market By Region, From 2019 - 2024 (USD Million)
  11. Global Microbiology Market By Region, From 2019 - 2024 (USD Million)
  12. Global Other IVD technologies Market By Region, From 2019 - 2024 (USD Million)
  13. Global Diabetes Market By Region, From 2019 - 2024 (USD Million)
  14. Global Infectious Diseases Market By Region, From 2019 - 2024 (USD Million)
  15. Global Oncology/Cancer Market By Region, From 2019 - 2024 (USD Million)
  16. Global Cardiology Market By Region, From 2019 - 2024 (USD Million) 
  17. Global Nephrology Market By Region, From 2019 - 2024 (USD Million)
  18. Global Autoimmune Diseases Market By Region, From 2019 - 2024 (USD Million)
  19. Global Drug Testing Market By Region, From 2019 - 2024 (USD Million)
  20. Global HIV Market By Region, From 2019 - 2024 (USD Million)
  21. North America Global In-Vitro Diagnostics Market Market By Region, From 2019 - 2024 (USD Million) 
  22. North America Global In-Vitro Diagnostics Market Market By Type, From 2019 - 2024 (USD Million)
  23. North America Instruments Market By Region, From 2019 - 2024 (USD Million)
  24. North America Reagents and Kits Market By Region, From 2019 - 2024 (USD Million)  
  25. North America Software Market By Region, From 2019 - 2024 (USD Million)
  26. North America Clinical Chemistry Market By Region, From 2019 - 2024 (USD Million)  
  27. North America Hematology Market By Region, From 2019 - 2024 (USD Million)
  28. North America Immunoassays Market By Region, From 2019 - 2024 (USD Million)
  29. North America Coagulation and Hemostasis Market By Region, From 2019 - 2024 (USD Million)
  30. North America Molecular Diagnostics Market By Region, From 2019 - 2024 (USD Million)
  31. North America Microbiology Market By Region, From 2019 - 2024 (USD Million) 
  32. North America Other IVD technologies Market By Region, From 2019 - 2024 (USD Million)
  33. North America Diabetes Market By Region, From 2019 - 2024 (USD Million)
  34. North America Infectious Diseases Market By Region, From 2019 - 2024 (USD Million)
  35. North America Oncology/Cancer Market By Region, From 2019 - 2024 (USD Million)   
  36. North America Cardiology Market By Region, From 2019 - 2024 (USD Million)
  37. North America Nephrology Market By Region, From 2019 - 2024 (USD Million) 
  38. North America Autoimmune Diseases Market By Region, From 2019 - 2024 (USD Million)
  39. North America Drug Testing Market By Region, From 2019 - 2024 (USD Million)
  40. North America HIV Market By Region, From 2019 - 2024 (USD Million)
  41. United States Market By Product, From 2019 - 2024 (USD Million)
  42. United States Market By Technology, From 2019 - 2024 (USD Million)
  43. United States Market By Application, From 2019 - 2024 (USD Million)
  44. Canada Market By Product, From 2019 - 2024 (USD Million)   
  45. Canada Market By Technology, From 2019 - 2024 (USD Million)
  46. Canada Market By Application, From 2019 - 2024 (USD Million)
  47. Europe Global In-Vitro Diagnostics Market Market By Region, From 2019 - 2024 (USD Million)
  48. Europe Global In-Vitro Diagnostics Market Market By Type, From 2019 - 2024 (USD Million)
  49. Europe Instruments Market By Region, From 2019 - 2024 (USD Million)
  50. Europe Reagents and Kits Market By Region, From 2019 - 2024 (USD Million) 
  51. Europe Software Market By Region, From 2019 - 2024 (USD Million)   
  52. Europe Clinical Chemistry Market By Region, From 2019 - 2024 (USD Million) 
  53. Europe Hematology Market By Region, From 2019 - 2024 (USD Million)
  54. Europe Immunoassays Market By Region, From 2019 - 2024 (USD Million)
  55. Europe Coagulation and Hemostasis Market By Region, From 2019 - 2024 (USD Million)
  56. Europe Molecular Diagnostics Market By Region, From 2019 - 2024 (USD Million)
  57. Europe Microbiology Market By Region, From 2019 - 2024 (USD Million)
  58. Europe Other IVD technologies Market By Region, From 2019 - 2024 (USD Million) 
  59. Europe Diabetes Market By Region, From 2019 - 2024 (USD Million)   
  60. Europe Infectious Diseases Market By Region, From 2019 - 2024 (USD Million)
  61. Europe Oncology/Cancer Market By Region, From 2019 - 2024 (USD Million)  
  62. Europe Cardiology Market By Region, From 2019 - 2024 (USD Million)
  63. Europe Nephrology Market By Region, From 2019 - 2024 (USD Million)
  64. Europe Autoimmune Diseases Market By Region, From 2019 - 2024 (USD Million)
  65. Europe Drug Testing Market By Region, From 2019 - 2024 (USD Million) 
  66. Europe HIV Market By Region, From 2019 - 2024 (USD Million) 
  67. U.K. Market By Product, From 2019 - 2024 (USD Million)
  68. U.K. Market By Technology, From 2019 - 2024 (USD Million)   
  69. U.K. Market By Application, From 2019 - 2024 (USD Million)   
  70. Germany Market By Product, From 2019 - 2024 (USD Million)
  71. Germany Market By Technology, From 2019 - 2024 (USD Million)
  72. Germany Market By Application, From 2019 - 2024 (USD Million)
  73. France Market By Product, From 2019 - 2024 (USD Million)
  74. France Market By Technology, From 2019 - 2024 (USD Million)
  75. France Market By Application, From 2019 - 2024 (USD Million) 
  76. Italy Market By Product, From 2019 - 2024 (USD Million)
  77. Italy Market By Technology, From 2019 - 2024 (USD Million)  
  78. Italy Market By Application, From 2019 - 2024 (USD Million)  
  79. Spain Market By Product, From 2019 - 2024 (USD Million)
  80. Spain Market By Technology, From 2019 - 2024 (USD Million)
  81. Spain Market By Application, From 2019 - 2024 (USD Million)
  82. Asia-Pacific Global In-Vitro Diagnostics Market Market By Region, From 2019 - 2024 (USD Million)
  83. Asia-Pacific Global In-Vitro Diagnostics Market Market By Type, From 2019 - 2024 (USD Million)
  84. Asia-Pacific Instruments Market By Region, From 2019 - 2024 (USD Million)
  85. Asia-Pacific Reagents and Kits Market By Region, From 2019 - 2024 (USD Million)
  86. Asia-Pacific Software Market By Region, From 2019 - 2024 (USD Million)
  87. Asia-Pacific Clinical Chemistry Market By Region, From 2019 - 2024 (USD Million)
  88. Asia-Pacific Hematology Market By Region, From 2019 - 2024 (USD Million)
  89. Asia-Pacific Immunoassays Market By Region, From 2019 - 2024 (USD Million)
  90. Asia-Pacific Coagulation and Hemostasis Market By Region, From 2019 - 2024 (USD Million)
  91. Asia-Pacific Molecular Diagnostics Market By Region, From 2019 - 2024 (USD Million) 
  92. Asia-Pacific Microbiology Market By Region, From 2019 - 2024 (USD Million)  
  93. Asia-Pacific Other IVD technologies Market By Region, From 2019 - 2024 (USD Million) 
  94. Asia-Pacific Diabetes Market By Region, From 2019 - 2024 (USD Million) 
  95. Asia-Pacific Infectious Diseases Market By Region, From 2019 - 2024 (USD Million)
  96. Asia-Pacific Oncology/Cancer Market By Region, From 2019 - 2024 (USD Million)
  97. Asia-Pacific Cardiology Market By Region, From 2019 - 2024 (USD Million)
  98. Asia-Pacific Nephrology Market By Region, From 2019 - 2024 (USD Million)
  99. Asia-Pacific Autoimmune Diseases Market By Region, From 2019 - 2024 (USD Million)
  100. Asia-Pacific Drug Testing Market By Region, From 2019 - 2024 (USD Million)   
  101. Asia-Pacific HIV Market By Region, From 2019 - 2024 (USD Million)
  102. China Market By Product, From 2019 - 2024 (USD Million)
  103. China Market By Technology, From 2019 - 2024 (USD Million)
  104. China Market By Application, From 2019 - 2024 (USD Million)
  105. India Market By Product, From 2019 - 2024 (USD Million)
  106. India Market By Technology, From 2019 - 2024 (USD Million) 
  107. India Market By Application, From 2019 - 2024 (USD Million) 
  108. Japan Market By Product, From 2019 - 2024 (USD Million)
  109. Japan Market By Technology, From 2019 - 2024 (USD Million)
  110. Japan Market By Application, From 2019 - 2024 (USD Million)
  111. Rest Of Asia-Pacific  Market By Product, From 2019 - 2024 (USD Million) 
  112. Rest Of Asia-Pacific  Market By Technology, From 2019 - 2024 (USD Million)
  113. Rest Of Asia-Pacific  Market By Application, From 2019 - 2024 (USD Million)
  114. Latin America Global In-Vitro Diagnostics Market Market By Region, From 2019 - 2024 (USD Million)   
  115. Latin America Global In-Vitro Diagnostics Market Market By Type, From 2019 - 2024 (USD Million)
  116. Latin America Instruments Market By Region, From 2019 - 2024 (USD Million)
  117. Latin America Reagents and Kits Market By Region, From 2019 - 2024 (USD Million)
  118. Latin America Software Market By Region, From 2019 - 2024 (USD Million) 
  119. Latin America Clinical Chemistry Market By Region, From 2019 - 2024 (USD Million)
  120. Latin America Hematology Market By Region, From 2019 - 2024 (USD Million)
  121. Latin America Immunoassays Market By Region, From 2019 - 2024 (USD Million)
  122. Latin America Coagulation and Hemostasis Market By Region, From 2019 - 2024 (USD Million)
  123. Latin America Molecular Diagnostics Market By Region, From 2019 - 2024 (USD Million)
  124. Latin America Microbiology Market By Region, From 2019 - 2024 (USD Million)
  125. Latin America Other IVD technologies Market By Region, From 2019 - 2024 (USD Million)
  126. Latin America Diabetes Market By Region, From 2019 - 2024 (USD Million) 
  127. Latin America Infectious Diseases Market By Region, From 2019 - 2024 (USD Million)  
  128. Latin America Oncology/Cancer Market By Region, From 2019 - 2024 (USD Million)
  129. Latin America Cardiology Market By Region, From 2019 - 2024 (USD Million)  
  130. Latin America Nephrology Market By Region, From 2019 - 2024 (USD Million)
  131. Latin America Autoimmune Diseases Market By Region, From 2019 - 2024 (USD Million) 
  132. Latin America Drug Testing Market By Region, From 2019 - 2024 (USD Million) 
  133. Latin America HIV Market By Region, From 2019 - 2024 (USD Million)
  134. Brazil Market By Product, From 2019 - 2024 (USD Million)
  135. Brazil Market By Technology, From 2019 - 2024 (USD Million)
  136. Brazil Market By Application, From 2019 - 2024 (USD Million)
  137. Mexico Market By Product, From 2019 - 2024 (USD Million)   
  138. Mexico Market By Technology, From 2019 - 2024 (USD Million)
  139. Mexico Market By Application, From 2019 - 2024 (USD Million)
  140. Rest of Latin America Market By Product, From 2019 - 2024 (USD Million)
  141. Rest of Latin America Market By Technology, From 2019 - 2024 (USD Million) 
  142. Rest of Latin America Market By Application, From 2019 - 2024 (USD Million) 
  143. Middle East & Africa Global In-Vitro Diagnostics Market Market By Region, From 2019 - 2024 (USD Million) 
  144. Middle East & Africa Global In-Vitro Diagnostics Market Market By Type, From 2019 - 2024 (USD Million)
  145. Middle East & Africa Instruments Market By Region, From 2019 - 2024 (USD Million)  
  146. Middle East & Africa Reagents and Kits Market By Region, From 2019 - 2024 (USD Million)
  147. Middle East & Africa Software Market By Region, From 2019 - 2024 (USD Million)
  148. Middle East & Africa Clinical Chemistry Market By Region, From 2019 - 2024 (USD Million)
  149. Middle East & Africa Hematology Market By Region, From 2019 - 2024 (USD Million)  
  150. Middle East & Africa Immunoassays Market By Region, From 2019 - 2024 (USD Million)
  151. Middle East & Africa Coagulation and Hemostasis Market By Region, From 2019 - 2024 (USD Million)  
  152. Middle East & Africa Molecular Diagnostics Market By Region, From 2019 - 2024 (USD Million) 
  153. Middle East & Africa Microbiology Market By Region, From 2019 - 2024 (USD Million)
  154. Middle East & Africa Other IVD technologies Market By Region, From 2019 - 2024 (USD Million)
  155. Middle East & Africa Diabetes Market By Region, From 2019 - 2024 (USD Million)
  156. Middle East & Africa Infectious Diseases Market By Region, From 2019 - 2024 (USD Million)
  157. Middle East & Africa Oncology/Cancer Market By Region, From 2019 - 2024 (USD Million)
  158. Middle East & Africa Cardiology Market By Region, From 2019 - 2024 (USD Million)
  159. Middle East & Africa Nephrology Market By Region, From 2018-2023 ( USD Billion )   

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 4255

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample